You are here: Industry Insights > blood cells

News List

Experimental gene therapy reverses sickle cell disease for three years EuropeanPharmaceuticalReview
December 15, 2021
A study of an investigational gene therapy for sickle cell disease at Columbia University Irving Medical Centre, US, has found that a single dose restored blood cells to their normal shape...
FDA approves Besremi to treat rare blood disease EuropeanPharmaceuticalReview
November 17, 2021
The FDA approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red blood cells.
Could this Novartis initiative finally cure sickle cell disease? pharmaceutical-technology
June 04, 2021
If you want to better understand how our genes can predispose us to disease, look to sickle cell disorder (SCD). It’s one of the oldest known and most common genetic disorders and affects millions of people around the world.
Using Epo against COVID-19 worldpharmanews
July 07, 2020
Erythropoietin (Epo) is actually a medication for anaemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19.
Low Levels of Key Blood Cells Could Signal Higher Death Risk drugs
January 14, 2020
A condition called lymphopenia -- low levels of lymphocyte blood cells -- could be an early warning for illness, a new study suggests.Danish researchers linked the condition to a 60% increased risk of death from any cause during the study period.
GSK, Plasticell sign deal to produce haematopoietic cells pharmatimes
October 19, 2017
GlaxoSmithKline and Plasticell have signed a collaboration agreement to produce haematopoietic cells from induced pluripotent stem cells (iPSCs).